Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Building a computerized disease management operating system

S R Arikian1, G G Mario, J J Doyle

  • 1Center for Health Outcomes and Economics, East Brunswick, New Jersey, USA.

Oncology (Williston Park, N.Y.)
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The burden of chemotherapy-induced nausea and vomiting in children receiving hematopoietic stem cell transplantation conditioning: a prospective study.

Bone marrow transplantation·2017
Same author

Using Genomic Location and Coalescent Simulation to Investigate Gene Tree Discordance in Medicago L.

Systematic biology·2017
Same author

Market Access of Implantable Medical Devices - Part Ii: Decision Drivers Across Global Markets.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Reimbursement Trends and Evidence Requirements for Ultra-Orphan Therapies Across Europe: Optimising Market Access in Increasingly Challenging Markets.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Global HTA Assessments of Ultra-Orphan Products: A Case Study Of Eculizumab (Soliris) and Iduronate-2-Sulfatase (Elaprase).

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Understanding Trends In Ophthalmologist Patient Selection And Care Based On Patterns Of Billing.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same journal

Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026
Same journal

Access to Care and the Affordable Care Act: Why Do Problems Exist 15 Years Later?

Oncology (Williston Park, N.Y.)·2026
Same journal

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review.

Oncology (Williston Park, N.Y.)·2026
Same journal

Perceived Social Support, Anxiety, and Depression Among Women With Breast Cancer.

Oncology (Williston Park, N.Y.)·2026
Same journal

Before Certainty.

Oncology (Williston Park, N.Y.)·2026
Same journal

Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus-Positive DLBCL: A Rare Concomitant Association.

Oncology (Williston Park, N.Y.)·2026
See all related articles

This study introduces an integrated disease management system for healthcare, enabling continuous monitoring of clinical and financial data to improve patient outcomes and control costs. Pilot studies demonstrate its analytic capabilities for robust health economic and pharmacoeconomic analysis.

Area of Science:

  • Health Informatics
  • Health Economics
  • Clinical Informatics

Background:

  • Healthcare systems face market pressures demanding improved efficiency, cost control, and clinical outcomes.
  • Effective disease management requires global analysis of complex, dynamic healthcare systems.
  • Data integration from point-of-care to continuum of care is crucial for comprehensive analysis.

Purpose of the Study:

  • To introduce an integrated disease management system developed by our center.
  • To enable continuous monitoring and assessment of clinical and financial information.
  • To provide robust outcomes, health economic, and pharmacoeconomic analysis throughout care delivery.

Main Methods:

  • Development of an integrated disease management system.

Related Experiment Videos

  • Incorporation of point-of-care data collection and continuum of care interfaces.
  • Pilot studies to evaluate the system's analytic capabilities and conceptual parameters.

    • Main Results:

    • The system allows clinicians to continuously monitor relevant clinical and financial data.
    • Pilot studies assessed the analytic capabilities for outcomes, health economics, and pharmacoeconomics.
    • The system supports rigorous analysis at every step of the care delivery process.

    Conclusions:

    • The integrated disease management system offers a robust solution for analyzing healthcare delivery.
    • It facilitates improved efficiency, cost control, and clinical outcomes through data-driven insights.
    • The system's design supports comprehensive health economic and pharmacoeconomic evaluations.